|
|
|
1
|
A bill to be entitled |
2
|
An act relating to controlled substances; amending s. |
3
|
893.04, F.S.; providing additional requirements for the |
4
|
dispensing of a controlled substance listed in Schedule |
5
|
II, Schedule III, or Schedule IV; providing rulemaking |
6
|
authority to the Board of Pharmacy; creating s. 893.055, |
7
|
F.S.; requiring the Department of Health to establish an |
8
|
electronic system to monitor the prescribing of controlled |
9
|
substances listed in Schedules II, III, and IV; requiring |
10
|
the dispensing of such controlled substances to be |
11
|
reported through the system; providing exceptions; |
12
|
providing reporting requirements; providing penalties; |
13
|
providing rulemaking authority to the department; |
14
|
requiring the department to cover all costs for the |
15
|
system; providing a continuing appropriation; creating s. |
16
|
893.065, F.S.; requiring the department to develop and |
17
|
adopt by rule the form and content for a counterfeit-proof |
18
|
prescription blank for voluntary use by physicians to |
19
|
prescribe a controlled substance listed in Schedule II, |
20
|
Schedule III, or Schedule IV; providing an appropriation; |
21
|
providing effective dates. |
22
|
|
23
|
Be It Enacted by the Legislature of the State of Florida: |
24
|
|
25
|
Section 1. Section 893.04, Florida Statutes, is amended to |
26
|
read: |
27
|
893.04 Pharmacist and practitioner.-- |
28
|
(1) A pharmacist, in good faith and in the course of |
29
|
professional practice only, may dispense controlled substances |
30
|
upon a written or oral prescription of a practitioner, under the |
31
|
following conditions: |
32
|
(a) Oral prescriptions must be promptly reduced to writing |
33
|
by the pharmacist. |
34
|
(b) The written prescription must be dated and signed by |
35
|
the prescribing practitioner on the day when issued. |
36
|
(c) There shall appear on the face of the prescription or |
37
|
written record thereof for the controlled substance the |
38
|
following information: |
39
|
1. The full name and address of the person for whom, or |
40
|
the owner of the animal for which, the controlled substance is |
41
|
dispensed. |
42
|
2. The full name and address of the prescribing |
43
|
practitioner and the practitioner's federal controlled substance |
44
|
registry number shall be printed thereon. |
45
|
3. If the prescription is for an animal, the species of |
46
|
animal for which the controlled substance is prescribed. |
47
|
4. The name of the controlled substance prescribed and the |
48
|
strength, quantity, and directions for use thereof. |
49
|
5. The number of the prescription, as recorded in the |
50
|
prescription files of the pharmacy in which it is filled. |
51
|
6. The initials of the pharmacist filling the prescription |
52
|
and the date filled. |
53
|
(d) The prescription shall be retained on file by the |
54
|
proprietor of the pharmacy in which it is filled for a period of |
55
|
2 years. |
56
|
(e) Affixed to the original container in which a |
57
|
controlled substance is delivered upon a prescription or |
58
|
authorized refill thereof, as hereinafter provided, there shall |
59
|
be a label bearing the following information: |
60
|
1. The name and address of the pharmacy from which such |
61
|
controlled substance was dispensed. |
62
|
2. The date on which the prescription for such controlled |
63
|
substance was filled. |
64
|
3. The number of such prescription, as recorded in the |
65
|
prescription files of the pharmacy in which it is filled. |
66
|
4. The name of the prescribing practitioner. |
67
|
5. The name of the patient for whom, or of the owner and |
68
|
species of the animal for which, the controlled substance is |
69
|
prescribed. |
70
|
6. The directions for the use of the controlled substance |
71
|
prescribed in the prescription. |
72
|
7. A clear, concise warning that it is a crime to transfer |
73
|
the controlled substance to any person other than the patient |
74
|
for whom prescribed. |
75
|
(f) A prescription for a controlled substance listed in |
76
|
Schedule II may be dispensed only upon a written prescription of |
77
|
a practitioner, except that in an emergency situation, as |
78
|
defined by regulation of the Department of Health, such |
79
|
controlled substance may be dispensed upon oral prescription but |
80
|
shall be limited to a 48-hour supply. No prescription for a |
81
|
controlled substance listed in Schedule II may be refilled. |
82
|
(g) No prescription for a controlled substance listed in |
83
|
ScheduleSchedules III, Schedule IV, or ScheduleV may be filled |
84
|
or refilled more than five times within a period of 6 months |
85
|
after the date on which the prescription was written unless the |
86
|
prescription is renewed by a practitioner. |
87
|
(2)(a) A pharmacist may not dispense a controlled |
88
|
substance listed in Schedule II, Schedule III, or Schedule IV to |
89
|
any individual without first obtaining suitable identification |
90
|
and documenting, in a log book kept by the pharmacist, the |
91
|
identity of the individual obtaining the controlled substance. |
92
|
The log book entry shall contain the printed name, address, |
93
|
phone number (if available), driver's license number or other |
94
|
suitable identification number, and signature of the person |
95
|
obtaining the controlled substance. If the individual does not |
96
|
have suitable identification or it is impracticable to obtain |
97
|
such identification, the pharmacist may dispense the controlled |
98
|
substance only when the pharmacist determines, in the exercise |
99
|
of her or his professional judgment, that the order is valid. In |
100
|
such case, the pharmacist or his or her designee must obtain the |
101
|
other information required by this paragraph and must sign the |
102
|
log book to indicate that suitable identification was not |
103
|
available and that the pharmacist's professional judgment was |
104
|
exercised prior to dispensing the controlled substance. The |
105
|
Board of Pharmacy may adopt, by rule, procedures for a |
106
|
pharmacist to verify the validity of a prescription for a |
107
|
controlled substance listed in Schedule II, Schedule III, or |
108
|
Schedule IV for circumstances when it is otherwise impracticable |
109
|
for the pharmacist to obtain suitable identification from the |
110
|
patient or the patient's agent. For purposes of this paragraph, |
111
|
identification is suitable only if it contains the photograph, |
112
|
printed name, and signature of the individual obtaining the |
113
|
controlled substance.
|
114
|
(b) Any pharmacist that dispenses by mail a controlled |
115
|
substance listed in Schedule II, Schedule III, or Schedule IV |
116
|
shall be exempt from the requirement to obtain suitable |
117
|
identification.
|
118
|
(c) Any controlled substance listed in Schedule III or |
119
|
Schedule IV may be dispensed by a pharmacist upon an oral |
120
|
prescription if, before filling the prescription, the pharmacist |
121
|
reduces it to writing. Such prescriptions must contain the date |
122
|
of the oral authorization.
|
123
|
(d) All prescriptions issued for a controlled substance |
124
|
listed in Schedule II, Schedule III, or Schedule IV must include |
125
|
both a written and numerical notation of the date and quantity |
126
|
on the face of the prescription.
|
127
|
(e) A pharmacist may not dispense more than a 30-day |
128
|
supply of a controlled substance listed in Schedule III upon an |
129
|
oral prescription.
|
130
|
(f) A pharmacist may not knowingly fill a prescription |
131
|
that has been mutilated or forged for a controlled substance |
132
|
listed in Schedule II, Schedule III, or Schedule IV. |
133
|
(3)(2)Notwithstanding the provisions of subsection (1), a |
134
|
pharmacist may dispense a one-time emergency refill of up to a |
135
|
72-hour supply of the prescribed medication for any medicinal |
136
|
drug other than a medicinal drug listed in Schedule II, in |
137
|
compliance with the provisions of s. 465.0275. |
138
|
(4)(3)The legal owner of any stock of controlled |
139
|
substances in a pharmacy, upon discontinuance of dealing in |
140
|
controlled substances, may sell said stock to a manufacturer, |
141
|
wholesaler, or pharmacy. Such controlled substances may be sold |
142
|
only upon an order form, when such an order form is required for |
143
|
sale by the drug abuse laws of the United States or this state, |
144
|
or regulations pursuant thereto. |
145
|
Section 2. Section 893.055, Florida Statutes, is created |
146
|
to read: |
147
|
893.055 Electronic monitoring system for prescription of |
148
|
controlled substances listed in Schedules II, III, and IV.--
|
149
|
(1) By January 1, 2004, the Department of Health shall |
150
|
design and establish an electronic system to monitor the |
151
|
prescribing of controlled substances listed in Schedules II, |
152
|
III, and IV by health care practitioners within the state or the |
153
|
dispensing of such controlled substances to an address within |
154
|
the state by a pharmacy permitted or registered by the Board of |
155
|
Pharmacy. |
156
|
(2) Any controlled substance listed in Schedule II, |
157
|
Schedule III, or Schedule IV that is dispensed in this state |
158
|
must be reported to the Department of Health through the system, |
159
|
as soon thereafter as possible but not more than 30 days after |
160
|
the date the controlled substance is dispensed, each time the |
161
|
controlled substance is dispensed. |
162
|
(3) This section does not apply to controlled substances: |
163
|
(a) Administered by a health care practitioner directly to |
164
|
a patient.
|
165
|
(b) Dispensed by a health care practitioner to a patient |
166
|
and limited to an amount adequate to treat the patient for a |
167
|
period of no more than 48 hours.
|
168
|
(c) Dispensed by a health care practitioner to an in- |
169
|
patient of a facility with an institutional pharmacy permit.
|
170
|
(d) Prescribed by a health care practitioner for a patient |
171
|
less than 16 years of age. |
172
|
(4) The data required to be reported under this section |
173
|
shall be determined by the Department of Health by rule but may |
174
|
include any data required under s. 893.04 and must include the |
175
|
category of professional licensure of the prescribing |
176
|
practitioner. |
177
|
(5) A dispenser must transmit the information required by |
178
|
this section in an electronic format approved by rule of the |
179
|
Board of Pharmacy after consultation with the Department of |
180
|
Health, unless a specific waiver is granted to that dispenser by |
181
|
the Department of Health. The information transmitted to the |
182
|
Department of Health under this section may be transmitted to |
183
|
any agency authorized to receive it, and that agency may |
184
|
maintain the information received for up to 12 months before |
185
|
purging it from its records. Notwithstanding the foregoing, any |
186
|
authorized agency receiving such information may maintain it |
187
|
longer than 12 months if the information is pertinent to an |
188
|
ongoing investigation arising under this section.
|
189
|
(6) Any person who willfully fails to report the |
190
|
dispensing of a controlled substance listed in Schedule II, |
191
|
Schedule III, or Schedule IV as required by this section commits |
192
|
a misdemeanor of the first degree, punishable as provided in s. |
193
|
775.082 or s. 775.083.
|
194
|
(7) The Department of Health shall adopt rules pursuant to |
195
|
ss. 120.536(1) and 120.54 necessary to implement and administer |
196
|
this section. |
197
|
(8) The Department of Health must cover all costs for the |
198
|
prescription monitoring system, and there is appropriated |
199
|
annually out of the General Revenue Fund, to be paid to the |
200
|
Administrative Trust Fund of the department, an amount necessary |
201
|
to cover such costs.
|
202
|
Section 3. Section 893.065, Florida Statutes, is created |
203
|
to read: |
204
|
893.065 Counterfeit-resistant prescription blanks for |
205
|
controlled substances listed in Schedules II, III, and IV.--The |
206
|
Department of Health shall develop and adopt by rule the form |
207
|
and content for a counterfeit-proof prescription blank which may |
208
|
be used by practitioners to prescribe a controlled substance |
209
|
listed in Schedule II, Schedule III, or Schedule IV. The |
210
|
Department of Health may require the prescription blanks to be |
211
|
printed on distinctive, watermarked paper and to bear the |
212
|
preprinted name, address, and category of professional licensure |
213
|
of the practitioner and that practitioner's federal registry |
214
|
number for controlled substances. The prescription blanks may |
215
|
not be transferred.
|
216
|
Section 4. There is appropriated from the General Revenue |
217
|
Fund to the Administrative Trust Fund of the Department of |
218
|
Health an amount sufficient to cover the costs for fiscal year |
219
|
2003-2004 of implementing the provisions of s. 893.055, Florida |
220
|
Statutes, as created by this act. This section shall take effect |
221
|
July 1, 2003.
|
222
|
Section 5. Except as otherwise provided herein, this act |
223
|
shall take effect January 1, 2004. |